EBR Systems is girding for US FDA approval of its novel heart lead in April and commercialisation by the end of the year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback